Phio Appoints Dr. Todd Plott to Board of Directors
Phio Pharmaceuticals announced the appointment of dermatologist Todd Plott to its board. The addition is expected to support the development of the company's siRNA drug candidate PH-762 for treating squamous cell carcinoma.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day